Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin M Anstee

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2011
Animal models in nonalcoholic steatohepatitis research: utility and clinical translationQuentin M Anstee
Gastroenterology & Hepatology|September 18, 2023
Potential Use of Artificial Intelligence in the Histologic Assessment of Nonalcoholic SteatohepatitisQuentin M Anstee
Alimentary Pharmacology & Therapeutics|May 11, 2019
Editorial: collagen proportionate area as a prognostic indicator in NAFLDFederico Ravaioli, Quentin M Anstee
Hepatology (Baltimore, Md.)|August 18, 2016
Changing epidemiology of chronic liver disease among ethnic groups in the United StatesStuart McPherson, Quentin M Anstee
Clinical Medicine (London, England)|April 28, 2018
Genetics of alcoholic liver disease and non-alcoholic steatohepatitisEmma Scott, Quentin M Anstee
Alimentary Pharmacology & Therapeutics|October 16, 2018
Editorial: hepatocellular carcinoma in non-cirrhotic NASH-a troubling realityMarie Boyle, Quentin M Anstee
Journal of Hepatology|June 5, 2012
S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utilityQuentin M Anstee, Christopher P Day
Nature Reviews. Gastroenterology & Hepatology|September 25, 2013
The genetics of NAFLDQuentin M Anstee, Christopher P Day
Seminars in Liver Disease|September 18, 2015
Foreword. Nonalcoholic Fatty Liver DiseaseChristopher P Day, Quentin M Anstee
Clinical Medicine (London, England)|December 5, 2015
An overview of the genetics, mechanisms and management of NAFLD and ALDRachel J Rowell, Quentin M Anstee
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2011
Animal models in nonalcoholic steatohepatitis research: utility and clinical translationQuentin M Anstee
Gastroenterology & Hepatology|September 18, 2023
Potential Use of Artificial Intelligence in the Histologic Assessment of Nonalcoholic SteatohepatitisQuentin M Anstee
Alimentary Pharmacology & Therapeutics|May 11, 2019
Editorial: collagen proportionate area as a prognostic indicator in NAFLDFederico Ravaioli, Quentin M Anstee
Hepatology (Baltimore, Md.)|August 18, 2016
Changing epidemiology of chronic liver disease among ethnic groups in the United StatesStuart McPherson, Quentin M Anstee
Clinical Medicine (London, England)|April 28, 2018
Genetics of alcoholic liver disease and non-alcoholic steatohepatitisEmma Scott, Quentin M Anstee
Alimentary Pharmacology & Therapeutics|October 16, 2018
Editorial: hepatocellular carcinoma in non-cirrhotic NASH-a troubling realityMarie Boyle, Quentin M Anstee
Journal of Hepatology|June 5, 2012
S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utilityQuentin M Anstee, Christopher P Day
Nature Reviews. Gastroenterology & Hepatology|September 25, 2013
The genetics of NAFLDQuentin M Anstee, Christopher P Day
Seminars in Liver Disease|September 18, 2015
Foreword. Nonalcoholic Fatty Liver DiseaseChristopher P Day, Quentin M Anstee
Clinical Medicine (London, England)|December 5, 2015
An overview of the genetics, mechanisms and management of NAFLD and ALDRachel J Rowell, Quentin M Anstee
Pageof 27